Evoke Pharma, Inc. (EVOK) NASDAQ

5.46

+0.34(+6.64%)

Updated at August 18 02:50PM

Currency In USD

Valuation

Market Cap8.42M
Enterprise Value-15,690
P/E Ratio-2.57
PEG Ratio-0.08
Price/Sales Ratio0.66
Price/Book Ratio2.23
Enterprise/Revenue0.01
Enterprise/EBITDA-0.04

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.44
Operating Margin-0.43

Management Effectiveness

Return On Assets-0.31
Return On Equity-1.02

Income Statement

Revenue10.25M
Revenue/Share4.55
Gross Profit9.89M
EBITDA-4.85M
Net Income-5.35M
Diluted EPS-2.81

Balance Sheet

Total Cash12.62M
Total Cash/Share4.95
Total Debt5.14M
Total Debt/Equity0.88
Current Ratio1.55
Book Value Per Share2.29

Price History

52-Week Change-13.95
52-Week High12.32
52-Week Low1.94
Moving Average 50 Days4.03
Moving Average 200 Days4.03

Statistics

Average Volume2.37M
Shares Outstanding1.49M
% Held by Institutions6.09

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:12
Last Split DateAugust 01, 2024